Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7360 p132
30 July 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Carers and liver patients added to flu target lists

Influenza immunisation will be given to carers of elderly and disabled people

Influenza immunisation will be given to carers of elderly and disabled people

2005–06 flu vaccine

The strains of flu virus recommended by the World Health Organization to be included in the components for the 2005-06 vaccine are:

· An A/New Caledonia/20/99(H1N1)-like virus

· An A/California/7/2004 (H3N2)-like virus

· A B/Shanghai/361/2002-like virus

Manufacturers supplying the UK market include: Chiron Vaccines, GlaxoSmithKline, MASTA, sanofi pasteur MSD, Solvay Healthcare and Wyeth Vaccines.

People with chronic liver disease and people who are the main carers for elderly or disabled persons are to be offered influenza immunisation this year as part of the flu immunisation campaigns in England and Wales.

Details of the campaigns have been sent to health care professionals, including pharmacists, this week. As in previous years, all people aged 65 years and over, and all those aged over six months who fall into specific clinical risk groups should be offered immunisation.

In addition to carers and people with liver disease, the groups who should be considered for immunisation include those with chronic respiratory disease, chronic heart disease, chronic renal disease, diabetes and those who are immunosuppressed. People who live in long-term residential care homes or other long-stay care facilities where rapid spread of infection is likely should also be offered flu immunisation.

Funding to support implementation of the programme will be provided to primary care trusts and local health boards later this year and will be allocated on a pro rata basis according to the size of the area’s elderly population. A range of providers may be commissioned under the scheme, with general and personal medical services contractors due to be paid £7.51 for every flu vaccination administered to at-risk patients.

NHS employees directly involved in patient care should be offered immunisation through their occupational health service. Funding for immunisation of NHS staff is the responsibility of individual trusts and employers.

The Department of Health and Welsh Assembly Government are again calling for improved uptake rates across the target groups and national publicity campaigns will run from October.

Details of the flu immunisation campaign in Scotland are due to be published shortly.

Back to Top


©The Pharmaceutical Journal